Examples of using Use in biocidal in English and their translations into Bulgarian
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Kurstaki, serotype 3a3b, strain ABTS-351,as an active substance for use in biocidal products of product-type 18( 1).
The approval of sulfuryl fluoride for use in biocidal products of product-type 8 will expire on 31 December 2018.
Commission Implementing Decision postponing the expiry date of approval of propiconazole for use in biocidal products of product-type 8.
It is therefore appropriate to approve tolylfluanid for use in biocidal products for product-type 21 subject to compliance with certain specifications and conditions.
Commission Implementing Regulation(EU)2015/419 of 12 March 2015 approving tolylfluanid as an active substance for use in biocidal products for product-type 21(1).
Whereas:(1) The active substance flocoumafen is approved for use in biocidal products of product-type 14 as a rodenticide under Regulation(EU) No 528/2012.
Commission Implementing Decision(EU)2016/110 of 27 January 2016 not approving triclosan as an existing active substance for use in biocidal products for product-type 1(1).
Cyphenothrin is approved as an active substance for use in biocidal products of product-type 18, subject to the specifications and conditions set out in the Annex.
Approving iodine, including polyvinylpyrrolidone iodine,as an existing active substance for use in biocidal products for product-types 1, 3, 4 and 22.
The approval of brodifacoum as an active substance for use in biocidal products of product-type 14 is renewed, subject to the specifications and conditions set out in the Annex.
Commission Implementing Regulation(EU)2017/1379 of 25 July 2017 renewing the approval of difenacoum as an active substance for use in biocidal products of product-type 14(1).
Furthermore, as permethrin is not under assessment nor approved(5) for use in biocidal products of product-type 19, the horse rug should not be claimed to have any repellent function.
Commission implementing Decision(EU)2019/1942 of 22 november 2019 not approving carbendazim as an existing active substance for use in biocidal products for product-type 9.
Peracetic acid is approved as an active substance for use in biocidal products for product-types 1, 2, 3, 4, 5 and 6, subject to the specifications and conditions set out in the Annex.
Commission Implementing Decision(EU)2020/27 of 13 January 2020 postponing the expiry date of approval of propiconazole for use in biocidal products of product-type 8( 1).
For reasons beyond the control of the applicant, the approval of sulfuryl fluoride for use in biocidal products of product-type 8 is likely to expire before a decision has been taken on its renewal.
Commission Implementing Decision(EU) 2018/1251 of 18 September 2018 not approving empenthrin as an existing active substance for use in biocidal products of product-type 18( 1).
It is therefore appropriate to postpone the expiry date of approval of sulfuryl fluoride for use in biocidal products of product-type 8 for a period of time sufficient to enable the examination of the application.
Commission Implementing Regulation(EU) 2015/417 of 12 March 2015 approving Bacillus sphaericus 2362 serotype H5a5b,strain ABTS1743 as an active substance for use in biocidal products for product-type 18( 1).
It is therefore appropriate to approve Bacillussphaericus 2362 serotype H5a5b, strain ABTS1743 for use in biocidal products for product-type 18 subject to compliance with certain specifications and conditions.
Commission Implementing Decision(EU)2016/107 of 27 January 2016 not approving cybutryne as an existing active substance for use in biocidal products for product-type 21(1).
Bacillus sphaericus 2362 serotype H5a5b, strain ABTS1743 shall be approved as an active substance for use in biocidal products for product-type 18, subject to the specifications and conditions set out in the Annex.
Commission Implementing Regulation(EU)2016/105 of 27 January 2016 approving biphenyl-2-ol as an existing active substance for use in biocidal products for product-types 1, 2, 4, 6 and 13(1).
Commission Implementing Decision(EU)2016/108 of 27 January 2016 not approving 2-Butanone, peroxide as an existing active substance for use in biocidal products for product-types 1 and 2(1).
Commission Implementing Decision(EU)2016/107 of 27 January 2016 not approving cybutryne as an existing active substance for use in biocidal products for product-type 21(Text with EEA relevance).
Commission implementing decision(EU) No 2016/135 of 29 January 2016 postponing the expiry dateof approval of flocoumafen, brodifacoum and warfarin for use in biocidal products for product-type 14.
By Commission Implementing Decision(EU) 2016/135(5), the initial expiry date of approval of flocoumafen,brodifacoum and warfarin for use in biocidal products of product-type 14 was postponed until 30 June 2018.
(7) Commission Implementing Regulation(EU)2017/1377 of 25 July 2017 renewing the approval of chlorophacinone as an active substance for use in biocidal products of product-type 14(see page 15 of this Official Journal).